Causes of Hair Loss & Modern Treatment Modalities
A scientific breakdown of androgenetic, telogenic, and nutritional hair loss etiologies, contrasting medical preservation therapies with surgical restoration.
Key points
- Dihydrotestosterone (DHT) synthesized via 5-alpha reductase drives 95% of male pattern hair loss.
- Shedding 50 to 100 hair strands daily represents normal turnover; sustained excess demands hematological testing.
- While medical therapies revitalize dormant follicles, surgical transplantation remains the sole cure for fibrotic areas.
1. Biological Etiology of Hair Loss & The Role of DHT
Hair thinning is a multifactorial dermatological disorder manifesting through distinct clinical pathways in men and women. In male pattern baldness (Androgenetic Alopecia), dihydrotestosterone (DHT) acts as the principal pathological catalyst. Follicles genetically programmed with androgen receptors overreact to DHT synthesized by the enzyme 5-alpha reductase. This triggers progressive follicular miniaturization: the active growth (anagen) phase shortens, hair shafts thin into vellus hairs, and the dermal papilla ultimately atrophies. In contrast, female pattern hair loss typically presents as diffuse thinning across the central vertex, driven by endocrine shifts (PCOS, perimenopause), severe ferritin deficiency, zinc depletion, or thyroid autoimmunity.
2. Secondary Triggers: Stress, Deficiencies & Telogen Effluvium
Beyond genetics, the most frequent cause of acute diffuse shedding is Telogen Effluvium. Major surgical procedures, severe systemic infections, childbirth, psychological trauma, crash dieting, and febrile illnesses can shock a large cohort of anagen hairs prematurely into the resting (telogen) phase. This shedding typically surfaces 2 to 3 months following the precipitating trigger. Nutritional deficiencies in Vitamin D and B12, along with autoimmune conditions such as Alopecia Areata, also represent common causes. Differentiating these reversible shedding events from permanent androgenetic balding requires meticulous trichoscopic evaluation and blood panels.
3. Medical Therapies: PRP, Mesotherapy & Pharmacological Agents
To salvage miniaturized, fragile follicles prior to irreversible fibrosis, modern clinical practice utilizes evidence-based medical regimens. Platelet-Rich Plasma (PRP) therapy harnesses autologous growth factors (PDGF, VEGF, TGF-beta) centrifuged from the patient’s own blood, micro-injecting them into the scalp to stimulate microvascular neoangiogenesis. Hair mesotherapy delivers targeted cocktails of biotin, zinc, biomimetic peptides, and micronutrients straight into the dermal papilla layer. Additionally, evidence-based pharmacotherapies supervised by physicians inhibit 5-alpha reductase or enhance scalp perfusion, slowing hair loss progression.
4. The Definitive Remedy: Hair Transplantation in Istanbul
In scalp regions where follicles have completely atrophied and scar tissue has replaced viable roots, surgical hair restoration (Sapphire FUE and DHI) represents the sole definitive cure. Resilient donor roots from the occipital region are permanently transplanted into thinning areas. At our Istanbul surgical center, we adopt a synergistic hybrid strategy: surgical transplantation restores bald sectors, while concurrent autologous PRP and mesotherapy preserve the vitality of surrounding native hair.
References
- Sinclair R. Male Pattern Androgenetic Alopecia. BMJ. 1998;317(7162):865-869.
- Headington JT. Telogen Effluvium: New Concepts and Review. Arch Dermatol. 1993;129(3):356-363.
- Gupta AK, Carviel J. A Systematic Review of PRP and Mesotherapy in Androgenetic Alopecia. J Cosmet Dermatol. 2021;20(8):2400-2415.